Article
Pharmacology & Pharmacy
Wenqi Li, Shuhua Pei, Xiaojing Zhang, Defei Qi, Wenke Zhang, Yuanyuan Dou, Ruohan Yang, Xin Yao, Zhansheng Zhang, Songqiang Xie, Dong Fang, Hua Sun
Summary: Cinobufotalin inhibits the metastasis and invasion of hepatocellular carcinoma (HCC) by downregulating beta-catenin, suggesting its potential as a metastasis inhibitor for HCC.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Review
Oncology
Xiaoyong Ge, Yuan Yao, Jing Li, Zhaonan Li, Xinwei Han
Summary: Hepatocellular carcinoma (HCC) is a primary liver cancer with high incidence and mortality rates. The epithelial-mesenchymal transition (EMT) mechanism plays a crucial role in metastasis in advanced HCC patients. LncRNAs are important regulators in HCC, offering potential therapeutic targets.
FRONTIERS IN ONCOLOGY
(2021)
Review
Pharmacology & Pharmacy
Alina-Veronica Ghionescu, Andrei Sorop, Simona Olimpia Dima
Summary: Hepatocellular carcinoma (HCC) is a major global health problem and the leading cause of cancer-related deaths, especially in advanced stages with limited treatment options. Tumor resistance in HCC is closely associated with the activation and reversal of the EMT phenomenon, which are modulated by noncoding RNAs (ncRNAs). ncRNAs, circulating in the tumor microenvironment encapsulated in exosomes, play significant roles as both tumor suppressors and oncogenic molecules, controlling the malignant potential of HCC cells. This review highlights recent advances in ncRNAs related to EMT and categorizes the described mechanisms as direct and indirect for better summarization, and discusses the regulatory mechanisms of exosomal ncRNAs in EMT-HCC via intercellular communication pathways.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Medicine, General & Internal
Bang-Hao Xu, Jing-Hang Jiang, Tao Luo, Zhi-Jun Jiang, Xin-Yu Liu, Le-Qun Li
Summary: This study identified 5 prognostic ERLs using TCGA database and bioinformatics, confirming their reliability as independent predictors of HCC risk and their potential predictive value for HCC prognosis. These ERLs were involved in functions related to tumor occurrence and migration.
Article
Biochemistry & Molecular Biology
Shuai Yang, Hui Li, Haipei Yao, Yao Zhang, Huiqian Bao, Liangjing Wu, Conghui Zhang, Min Li, Le Feng, Jingfa Zhang, Zhi Zheng, Guotong Xu, Fang Wang
Summary: The study revealed that lncRNA ERLR plays a role in TGF-beta 1-induced EMT in human RPE cells and is involved in the pathogenesis of PVR, providing new insights into the mechanism and treatment of the disease.
CELL DEATH AND DIFFERENTIATION
(2021)
Article
Oncology
Zewei Lin, Jikui Liu
Summary: The study reveals that lncRNA DQ786243 (lncDQ) plays a role in promoting hepatocellular carcinoma (HCC) progression by modulating the expression of miR-15b-5p and Wnt3A. Low levels of miR-15b-5p are associated with poor prognoses for HCC patients, while silencing lncDQ can attenuate proliferation and invasion of liver cancer and HCC cells.
MOLECULAR MEDICINE REPORTS
(2021)
Review
Medicine, Research & Experimental
Xiuming Zhu, Hongming Pan, Lili Liu
Summary: HCC is a common and aggressive malignancy with poor prognosis, with studies on dysregulated lncRNAs playing a crucial role in discovering potential diagnostic and therapeutic targets.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Azusa Kitao, Osamu Matsui, Yu Zhang, Takahiro Ogi, Satoko Nakada, Yasunori Sato, Kenichi Harada, Norihide Yoneda, Kazuto Kozaka, Dai Inoue, Kotaro Yoshida, Wataru Koda, Taro Yamashita, Tatsuya Yamashita, Shuichi Kaneko, Satoshi Kobayashi, Toshifumi Gabata
Summary: Imaging characteristics of P53-mutated hepatocellular carcinoma (HCC) can be determined using dynamic CT and gadoxetic acid-enhanced MRI, and they are correlated with clinical features, pathologic findings, and prognosis. Dilated vasculature at the arterial phase of dynamic CT and a lower relative enhancement ratio at the hepatobiliary phase of gadoxetic acid-enhanced MRI are useful markers for predicting P53-mutated HCC.
Article
Oncology
Xiu Chen, Yu Zhang, Pingping Zhang, Mengzhu Wei, Tian Tian, Yanling Guan, Chenchen Han, Wei Wei, Yang Ma
Summary: IGFBP2 is found to be a key regulator in HCC, and its overexpression is associated with the aggressive clinical features of the disease. Through experiments, it is demonstrated that the overexpression of IGFBP2 accelerates the metastatic potential of HCC cells and is mediated by the Wnt/beta-catenin signaling pathway.
INFECTIOUS AGENTS AND CANCER
(2023)
Article
Oncology
Baiyang Chen, Yang Gu, Hui Shen, Qiangsheng Liu, Hongbo Wang, Yabo Li, Xifan Liu, Yu Liu, Qinghao Du, Huapeng Sun, Xiaofeng Liao
Summary: Borealin, a putative oncogene, is found to be enhanced in HCC tissue samples and hepatoma cells, and it promotes the growth and metastasis of HCC by activating the Wnt/β-catenin signaling pathway. These findings contribute to the understanding of HCC tumorigenesis and development and highlight the significance of Borealin in HCC diagnosis and treatment.
JOURNAL OF HEPATOCELLULAR CARCINOMA
(2022)
Article
Oncology
Yang Yang, Pengwei Ren, Xiaofeng Liu, Xiaoyan Sun, Chunfeng Zhang, Xiaojuan Du, Baocai Xing
Summary: This study found that PPP1R26 is upregulated in hepatocellular carcinoma (HCC) and is significantly associated with metastasis and poor patient survival. PPP1R26 promotes glycolysis by enhancing the splicing of PKM2 and activates epithelial-mesenchymal transition (EMT) by forming a PPP1R26-PKM2-TGIF2 complex, driving the progression of HCC.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
(2022)
Article
Engineering, Biomedical
Zhixiong Chen, Xi Chu, Jinghong Xu
Summary: This study identified differentially expressed EMT-related lncRNAs and mRNAs in keloid tissues compared to normal tissues and interpreted their functions. The differentially expressed mRNAs were found to function in the extracellular matrix, protein binding, the positive regulation of cellular processes, the Set1C/COMPASS complex, and histone acetyltransferase activity. The lncRNA XLOC_000587 may promote cell proliferation and migration by enhancing the expression of ENAH, while AF268386 may facilitate the invasive growth of keloids by upregulating DDR2.
BIOMEDICAL ENGINEERING ONLINE
(2022)
Article
Developmental Biology
Tiffany L. Dill, Alina Carroll, Amanda Pinheiro, Jiachen Gao, Francisco J. Naya
Summary: The long noncoding RNA Meg3 plays a crucial role in regulating EMT, affecting myoblast differentiation and skeletal muscle regeneration. Inhibition of Meg3 induces EMT and suppresses cell state transitions, highlighting its key role in promoting differentiation of myoblasts. The study also demonstrates that Meg3-dependent Ezh2 activity impacts epigenetic alterations associated with TGF beta activation, providing insights into the mechanisms of muscle development.
Article
Cell Biology
Yu Lei, Wei Yan, Zhuoying Lin, Jingmei Liu, Dean Tian, Ping Han
Summary: Complete EMT is not necessary for HCC progression. Overexpression of key p-EMT-related genes P4HA2, ITGA5, MMP9, SPP1 and down-regulation of MT1X were found in HCC tissues, which were significantly associated with poor prognosis of HCC patients. An mRNA-miRNA-lncRNA subnetwork containing p-EMT-related genes was successfully constructed, suggesting their potential as prognostic biomarkers for HCC.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2021)
Retraction
Cell Biology
Xinggang Guo, Hongqi Xiao, Sihong Guo, Jing Li, Yuxia Wang, Jie Chen, Ge Lou
Summary: The article published on October 26, 2018, has been retracted due to flaws and inconsistencies between results presented and experimental methods described, rendering the conclusions invalid.
JOURNAL OF CELLULAR PHYSIOLOGY
(2022)
Review
Oncology
Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu
Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.
Article
Oncology
Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang
Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.
Article
Oncology
Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge
Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.
Article
Oncology
Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi
Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.
Article
Oncology
Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang
Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.